An experimental study and a randomized, double-blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against nonrotavirus diarrhea

Autor: Luis E Sarrazin-Davila, Vanessa Liévin-Le Moal, Alain L. Servin
Přispěvatelé: Codogno, Patrice, Signalisation et physiopathologie des cellules épithéliales, Université Paris-Sud - Paris 11 (UP11)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Pediatrics, Hospital Clinica Kennedy
Rok vydání: 2007
Předmět:
Male
medicine.disease_cause
0302 clinical medicine
Lactobacillus acidophilus
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Rotavirus
Lactobacillus
Medicine
MESH: Double-Blind Method
Cells
Cultured

MESH: Treatment Outcome
0303 health sciences
education.field_of_study
biology
MESH: Escherichia coli
MESH: Infant
3. Good health
Diarrhea
[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology
Treatment Outcome
Rehydration Solutions
[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Female
medicine.symptom
MESH: Cells
Cultured

Population
Context (language use)
Placebo
Microbiology
03 medical and health sciences
Double-Blind Method
030225 pediatrics
Escherichia coli
Humans
education
[SDV.MP] Life Sciences [q-bio]/Microbiology and Parasitology
MESH: Humans
030306 microbiology
business.industry
Probiotics
Infant
biology.organism_classification
MESH: Diarrhea
Infantile

MESH: Lactobacillus acidophilus
MESH: Male
Pediatrics
Perinatology and Child Health

Diarrhea
Infantile

business
MESH: Female
Bacteria
MESH: Probiotics
MESH: Rehydration Solutions
Zdroj: Pediatrics
Pediatrics, American Academy of Pediatrics, 2007, 120 (4), pp.e795-803. ⟨10.1542/peds.2006-2930⟩
ISSN: 1098-4275
0031-4005
DOI: 10.1542/peds.2006-2930⟩
Popis: OBJECTIVE. Previous studies have shown that selected strains of Lactobacillus have the capacity to antagonize rotavirus-induced diarrhea. However, only a few reports have documented their efficacy against nonrotavirus diarrhea. This study involved an experimental investigation and a clinical trial of the antisecretory activity of Lactobacillus acidophilus strain LB in the context of nonrotavirus diarrhea.METHODS. The activity of a culture of L acidophilus LB or of the lyophilized, heat-killed L acidophilus LB bacteria plus their spent culture medium was tested in inhibiting the formation of fluid-formed domes in cultured human intestinal Caco-2/TC7 cell monolayers infected with diarrheagenic, diffusely adhering Afa/Dr Escherichia coli C1845 bacteria. A randomized, double-blind, placebo-controlled clinical trial of male or female children who were 10 months of age and presented with nonrotavirus, well-established diarrhea was conducted to evaluate the therapeutic efficacy of a pharmaceutical preparation that contains 10 billion heat-killed L acidophilus LB plus 160 mg of spent culture medium.RESULTS. Infection of the cells with C1845 bacteria that were treated with L acidophilus LB culture or the lyophilized, heat-killed L acidophilus LB bacteria plus their culture medium produced a dosage-dependent decrease in the number of fluid-formed domes as compared with cells that were infected with untreated C1845 bacteria. The clinical results show that in selected and controlled homogeneous groups of children with well-established, nonrotavirus diarrhea, adding lyophilized, heat-killed L acidophilus LB bacteria plus their culture medium to a solution of oral rehydration solution shortened by 1 day the recovery time (ie, the time until the first normal stool was passed) as compared with children who received placebo oral rehydration solution.CONCLUSIONS. Heat-killed L acidophilus LB plus its culture medium antagonizes the C1845-induced increase in paracellular permeability in intestinal Caco-2/TC7 cells and produces a clinically significant benefit in the management of children with nonrotavirus, well-established diarrhea.
Databáze: OpenAIRE